Modified Acarbose Pentasaccharide

Star0

DB04439ExperimentalSmall molecule

Modified Acarbose Pentasaccharide: Overview.

Formula / weight: C₃₁H₅₃NO₂₂ · 791.746 g/mol (avg)

Resolves to

Compound

PubChem447014

Structure

InChIKeyQWNATFSCUHKKDP-WYKVUHPSSA-NSMILES

[H][C@]1(C)O[C@]([H])(O[C@]2([H])C(CO)=C[C@]([H])(N[C@]3([H])[C@@]([H])(C)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O

Targets

P80099mgtA

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Modified Acarbose Pentasaccharide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account